I agree, CBT is certainly no panacea, and as mentioned in the post, for those at the moderate to severe end of the spectrum, or for those where CBT is ineffective, it may be the case that medication is the only viable solution.
Y Combinator has actually funded several companies looking at the usage of various drug-based mental health treatments, including Osmind (S20) and another company in this batch (S21) who are looking at the use of psychedelic therapeutics for mental health, although none are addressing your specific issue with availability / accessibility which is a tricky one with respect to legislation and regulation.
Y Combinator has actually funded several companies looking at the usage of various drug-based mental health treatments, including Osmind (S20) and another company in this batch (S21) who are looking at the use of psychedelic therapeutics for mental health, although none are addressing your specific issue with availability / accessibility which is a tricky one with respect to legislation and regulation.